0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Serum Gonadotrophin for Injection Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-27K16946
Home | Market Reports | Health| Pharmacy
Global Serum Gonadotrophin for Injection Market Research Report 2024
BUY CHAPTERS

Global Serum Gonadotrophin for Injection Market Research Report 2026

Code: QYRE-Auto-27K16946
Report
2026-04-10
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Serum Gonadotrophin for Injection Market Size

The global Serum Gonadotrophin for Injection market was valued at US$ 280 million in 2025 and is anticipated to reach US$ 388 million by 2032, at a CAGR of 4.8% from 2026 to 2032.

Serum Gonadotrophin for Injection Market

Serum Gonadotrophin for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Serum Gonadotrophin for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Serum gonadotropin for injection is a hormone drug whose main component is pregnant mare serum gonadotropin (PMSG). The action of serum gonadotropin is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The North American market for Serum Gonadotrophin for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Serum Gonadotrophin for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Serum Gonadotrophin for Injection include MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Serum Gonadotrophin for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Serum Gonadotrophin for Injection. The Serum Gonadotrophin for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Serum Gonadotrophin for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Serum Gonadotrophin for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Serum Gonadotrophin for Injection Market Report

Report Metric Details
Report Name Serum Gonadotrophin for Injection Market
Accounted market size in 2025 US$ 280 million
Forecasted market size in 2032 US$ 388 million
CAGR 4.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 1000 IU/Unit
  • 5000 IU/Unit
  • Others
by Application
  • Pig
  • Cattle
  • Sheep
  • Horse
  • Other Animals
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Serum Gonadotrophin for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Serum Gonadotrophin for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Serum Gonadotrophin for Injection Market growing?

Ans: The Serum Gonadotrophin for Injection Market witnessing a CAGR of 4.8% during the forecast period 2026-2032.

What is the Serum Gonadotrophin for Injection Market size in 2032?

Ans: The Serum Gonadotrophin for Injection Market size in 2032 will be US$ 388 million.

Who are the main players in the Serum Gonadotrophin for Injection Market report?

Ans: The main players in the Serum Gonadotrophin for Injection Market are MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical

What are the Application segmentation covered in the Serum Gonadotrophin for Injection Market report?

Ans: The Applications covered in the Serum Gonadotrophin for Injection Market report are Pig, Cattle, Sheep, Horse, Other Animals

What are the Type segmentation covered in the Serum Gonadotrophin for Injection Market report?

Ans: The Types covered in the Serum Gonadotrophin for Injection Market report are 1000 IU/Unit, 5000 IU/Unit, Others

1 Serum Gonadotrophin for Injection Market Overview
1.1 Product Definition
1.2 Serum Gonadotrophin for Injection by Type
1.2.1 Global Serum Gonadotrophin for Injection Market Value by Type: 2025 vs 2032
1.2.2 1000 IU/Unit
1.2.3 5000 IU/Unit
1.2.4 Others
1.3 Serum Gonadotrophin for Injection by Application
1.3.1 Global Serum Gonadotrophin for Injection Market Value by Application: 2025 vs 2032
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Horse
1.3.6 Other Animals
1.4 Global Serum Gonadotrophin for Injection Market Size Estimates and Forecasts
1.4.1 Global Serum Gonadotrophin for Injection Revenue 2021–2032
1.4.2 Global Serum Gonadotrophin for Injection Sales 2021–2032
1.4.3 Global Serum Gonadotrophin for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Serum Gonadotrophin for Injection Market Competition by Manufacturers
2.1 Global Serum Gonadotrophin for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Serum Gonadotrophin for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Serum Gonadotrophin for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Serum Gonadotrophin for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Serum Gonadotrophin for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Serum Gonadotrophin for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Serum Gonadotrophin for Injection, Date of Entry into the Industry
2.8 Global Serum Gonadotrophin for Injection Market Competitive Situation and Trends
2.8.1 Global Serum Gonadotrophin for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Serum Gonadotrophin for Injection Players Market Share by Revenue
2.8.3 Global Serum Gonadotrophin for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Serum Gonadotrophin for Injection Market Scenario by Region
3.1 Global Serum Gonadotrophin for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Serum Gonadotrophin for Injection Sales by Region: 2021–2032
3.2.1 Global Serum Gonadotrophin for Injection Sales by Region: 2021–2026
3.2.2 Global Serum Gonadotrophin for Injection Sales by Region: 2027–2032
3.3 Global Serum Gonadotrophin for Injection Revenue by Region: 2021–2032
3.3.1 Global Serum Gonadotrophin for Injection Revenue by Region: 2021–2026
3.3.2 Global Serum Gonadotrophin for Injection Revenue by Region: 2027–2032
3.4 North America Serum Gonadotrophin for Injection Market Facts & Figures by Country
3.4.1 North America Serum Gonadotrophin for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Serum Gonadotrophin for Injection Sales by Country (2021–2032)
3.4.3 North America Serum Gonadotrophin for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Serum Gonadotrophin for Injection Market Facts & Figures by Country
3.5.1 Europe Serum Gonadotrophin for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Serum Gonadotrophin for Injection Sales by Country (2021–2032)
3.5.3 Europe Serum Gonadotrophin for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serum Gonadotrophin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Serum Gonadotrophin for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Serum Gonadotrophin for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Serum Gonadotrophin for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Serum Gonadotrophin for Injection Market Facts & Figures by Country
3.7.1 Latin America Serum Gonadotrophin for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Serum Gonadotrophin for Injection Sales by Country (2021–2032)
3.7.3 Latin America Serum Gonadotrophin for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Serum Gonadotrophin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Serum Gonadotrophin for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Serum Gonadotrophin for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Serum Gonadotrophin for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Serum Gonadotrophin for Injection Sales by Type (2021–2032)
4.1.1 Global Serum Gonadotrophin for Injection Sales by Type (2021–2026)
4.1.2 Global Serum Gonadotrophin for Injection Sales by Type (2027–2032)
4.1.3 Global Serum Gonadotrophin for Injection Sales Market Share by Type (2021–2032)
4.2 Global Serum Gonadotrophin for Injection Revenue by Type (2021–2032)
4.2.1 Global Serum Gonadotrophin for Injection Revenue by Type (2021–2026)
4.2.2 Global Serum Gonadotrophin for Injection Revenue by Type (2027–2032)
4.2.3 Global Serum Gonadotrophin for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Serum Gonadotrophin for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Serum Gonadotrophin for Injection Sales by Application (2021–2032)
5.1.1 Global Serum Gonadotrophin for Injection Sales by Application (2021–2026)
5.1.2 Global Serum Gonadotrophin for Injection Sales by Application (2027–2032)
5.1.3 Global Serum Gonadotrophin for Injection Sales Market Share by Application (2021–2032)
5.2 Global Serum Gonadotrophin for Injection Revenue by Application (2021–2032)
5.2.1 Global Serum Gonadotrophin for Injection Revenue by Application (2021–2026)
5.2.2 Global Serum Gonadotrophin for Injection Revenue by Application (2027–2032)
5.2.3 Global Serum Gonadotrophin for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Serum Gonadotrophin for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSD Animal Health Serum Gonadotrophin for Injection Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Ceva Santé Animale
6.2.1 Ceva Santé Animale Company Information
6.2.2 Ceva Santé Animale Description and Business Overview
6.2.3 Ceva Santé Animale Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Ceva Santé Animale Serum Gonadotrophin for Injection Product Portfolio
6.2.5 Ceva Santé Animale Recent Developments/Updates
6.3 Syntex SA
6.3.1 Syntex SA Company Information
6.3.2 Syntex SA Description and Business Overview
6.3.3 Syntex SA Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Syntex SA Serum Gonadotrophin for Injection Product Portfolio
6.3.5 Syntex SA Recent Developments/Updates
6.4 Bioveta
6.4.1 Bioveta Company Information
6.4.2 Bioveta Description and Business Overview
6.4.3 Bioveta Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioveta Serum Gonadotrophin for Injection Product Portfolio
6.4.5 Bioveta Recent Developments/Updates
6.5 Ningbo Sansheng Biological Technology
6.5.1 Ningbo Sansheng Biological Technology Company Information
6.5.2 Ningbo Sansheng Biological Technology Description and Business Overview
6.5.3 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Product Portfolio
6.5.5 Ningbo Sansheng Biological Technology Recent Developments/Updates
6.6 Ningbo Second Hormone Factory
6.6.1 Ningbo Second Hormone Factory Company Information
6.6.2 Ningbo Second Hormone Factory Description and Business Overview
6.6.3 Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Product Portfolio
6.6.5 Ningbo Second Hormone Factory Recent Developments/Updates
6.7 Chifeng Bo-en Pharmaceutical
6.7.1 Chifeng Bo-en Pharmaceutical Company Information
6.7.2 Chifeng Bo-en Pharmaceutical Description and Business Overview
6.7.3 Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Product Portfolio
6.7.5 Chifeng Bo-en Pharmaceutical Recent Developments/Updates
6.8 Guangzhou Vbio-Pharma
6.8.1 Guangzhou Vbio-Pharma Company Information
6.8.2 Guangzhou Vbio-Pharma Description and Business Overview
6.8.3 Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Product Portfolio
6.8.5 Guangzhou Vbio-Pharma Recent Developments/Updates
6.9 JALLY
6.9.1 JALLY Company Information
6.9.2 JALLY Description and Business Overview
6.9.3 JALLY Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 JALLY Serum Gonadotrophin for Injection Product Portfolio
6.9.5 JALLY Recent Developments/Updates
6.10 Ningbo Creator Animal Pharmaceutical
6.10.1 Ningbo Creator Animal Pharmaceutical Company Information
6.10.2 Ningbo Creator Animal Pharmaceutical Description and Business Overview
6.10.3 Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Product Portfolio
6.10.5 Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serum Gonadotrophin for Injection Industry Chain Analysis
7.2 Serum Gonadotrophin for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serum Gonadotrophin for Injection Production Mode & Process Analysis
7.4 Serum Gonadotrophin for Injection Sales and Marketing
7.4.1 Serum Gonadotrophin for Injection Sales Channels
7.4.2 Serum Gonadotrophin for Injection Distributors
7.5 Serum Gonadotrophin for Injection Customer Analysis
8 Serum Gonadotrophin for Injection Market Dynamics
8.1 Serum Gonadotrophin for Injection Industry Trends
8.2 Serum Gonadotrophin for Injection Market Drivers
8.3 Serum Gonadotrophin for Injection Market Challenges
8.4 Serum Gonadotrophin for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Serum Gonadotrophin for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Serum Gonadotrophin for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Serum Gonadotrophin for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Serum Gonadotrophin for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Serum Gonadotrophin for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Serum Gonadotrophin for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Serum Gonadotrophin for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Serum Gonadotrophin for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Serum Gonadotrophin for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Serum Gonadotrophin for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Serum Gonadotrophin for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Serum Gonadotrophin for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Serum Gonadotrophin for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Serum Gonadotrophin for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Serum Gonadotrophin for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Serum Gonadotrophin for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Serum Gonadotrophin for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Serum Gonadotrophin for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Serum Gonadotrophin for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Serum Gonadotrophin for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Serum Gonadotrophin for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Serum Gonadotrophin for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Serum Gonadotrophin for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Serum Gonadotrophin for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Serum Gonadotrophin for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Serum Gonadotrophin for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Serum Gonadotrophin for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Serum Gonadotrophin for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Serum Gonadotrophin for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Serum Gonadotrophin for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Serum Gonadotrophin for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Serum Gonadotrophin for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Serum Gonadotrophin for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Serum Gonadotrophin for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Serum Gonadotrophin for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Serum Gonadotrophin for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Serum Gonadotrophin for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Serum Gonadotrophin for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Serum Gonadotrophin for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Serum Gonadotrophin for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Serum Gonadotrophin for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Serum Gonadotrophin for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Serum Gonadotrophin for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Serum Gonadotrophin for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Serum Gonadotrophin for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Serum Gonadotrophin for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Serum Gonadotrophin for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Serum Gonadotrophin for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Serum Gonadotrophin for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Serum Gonadotrophin for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Serum Gonadotrophin for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Serum Gonadotrophin for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Serum Gonadotrophin for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Serum Gonadotrophin for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Serum Gonadotrophin for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Serum Gonadotrophin for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Serum Gonadotrophin for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. MSD Animal Health Company Information
 Table 71. MSD Animal Health Description and Business Overview
 Table 72. MSD Animal Health Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. MSD Animal Health Serum Gonadotrophin for Injection Product
 Table 74. MSD Animal Health Recent Developments/Updates
 Table 75. Ceva Santé Animale Company Information
 Table 76. Ceva Santé Animale Description and Business Overview
 Table 77. Ceva Santé Animale Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Ceva Santé Animale Serum Gonadotrophin for Injection Product
 Table 79. Ceva Santé Animale Recent Developments/Updates
 Table 80. Syntex SA Company Information
 Table 81. Syntex SA Description and Business Overview
 Table 82. Syntex SA Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Syntex SA Serum Gonadotrophin for Injection Product
 Table 84. Syntex SA Recent Developments/Updates
 Table 85. Bioveta Company Information
 Table 86. Bioveta Description and Business Overview
 Table 87. Bioveta Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Bioveta Serum Gonadotrophin for Injection Product
 Table 89. Bioveta Recent Developments/Updates
 Table 90. Ningbo Sansheng Biological Technology Company Information
 Table 91. Ningbo Sansheng Biological Technology Description and Business Overview
 Table 92. Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Product
 Table 94. Ningbo Sansheng Biological Technology Recent Developments/Updates
 Table 95. Ningbo Second Hormone Factory Company Information
 Table 96. Ningbo Second Hormone Factory Description and Business Overview
 Table 97. Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Product
 Table 99. Ningbo Second Hormone Factory Recent Developments/Updates
 Table 100. Chifeng Bo-en Pharmaceutical Company Information
 Table 101. Chifeng Bo-en Pharmaceutical Description and Business Overview
 Table 102. Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Product
 Table 104. Chifeng Bo-en Pharmaceutical Recent Developments/Updates
 Table 105. Guangzhou Vbio-Pharma Company Information
 Table 106. Guangzhou Vbio-Pharma Description and Business Overview
 Table 107. Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Product
 Table 109. Guangzhou Vbio-Pharma Recent Developments/Updates
 Table 110. JALLY Company Information
 Table 111. JALLY Description and Business Overview
 Table 112. JALLY Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. JALLY Serum Gonadotrophin for Injection Product
 Table 114. JALLY Recent Developments/Updates
 Table 115. Ningbo Creator Animal Pharmaceutical Company Information
 Table 116. Ningbo Creator Animal Pharmaceutical Description and Business Overview
 Table 117. Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Product
 Table 119. Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Serum Gonadotrophin for Injection Distributors List
 Table 123. Serum Gonadotrophin for Injection Customers List
 Table 124. Serum Gonadotrophin for Injection Market Trends
 Table 125. Serum Gonadotrophin for Injection Market Drivers
 Table 126. Serum Gonadotrophin for Injection Market Challenges
 Table 127. Serum Gonadotrophin for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Serum Gonadotrophin for Injection
 Figure 2. Global Serum Gonadotrophin for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Serum Gonadotrophin for Injection Market Share by Type: 2025 & 2032
 Figure 4. 1000 IU/Unit Product Picture
 Figure 5. 5000 IU/Unit Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Serum Gonadotrophin for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Serum Gonadotrophin for Injection Market Share by Application: 2025 & 2032
 Figure 9. Pig
 Figure 10. Cattle
 Figure 11. Sheep
 Figure 12. Horse
 Figure 13. Other Animals
 Figure 14. Global Serum Gonadotrophin for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Serum Gonadotrophin for Injection Market Size (US$ Million), 2021–2032
 Figure 16. Global Serum Gonadotrophin for Injection Sales (K Units), 2021–2032
 Figure 17. Global Serum Gonadotrophin for Injection Average Price (US$/Unit), 2021–2032
 Figure 18. Serum Gonadotrophin for Injection Report Years Considered
 Figure 19. Serum Gonadotrophin for Injection Sales Share by Manufacturers in 2025
 Figure 20. Global Serum Gonadotrophin for Injection Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Serum Gonadotrophin for Injection Players: Market Share by Revenue in Serum Gonadotrophin for Injection in 2025
 Figure 22. Serum Gonadotrophin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Serum Gonadotrophin for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Serum Gonadotrophin for Injection Sales Market Share by Country (2021–2032)
 Figure 25. North America Serum Gonadotrophin for Injection Revenue Market Share by Country (2021–2032)
 Figure 26. United States Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Serum Gonadotrophin for Injection Sales Market Share by Country (2021–2032)
 Figure 29. Europe Serum Gonadotrophin for Injection Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Serum Gonadotrophin for Injection Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Serum Gonadotrophin for Injection Revenue Market Share by Region (2021–2032)
 Figure 37. China Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Serum Gonadotrophin for Injection Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Serum Gonadotrophin for Injection Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Serum Gonadotrophin for Injection Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Serum Gonadotrophin for Injection Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Serum Gonadotrophin for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Serum Gonadotrophin for Injection by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Serum Gonadotrophin for Injection by Type (2021–2032)
 Figure 57. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Serum Gonadotrophin for Injection by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Serum Gonadotrophin for Injection by Application (2021–2032)
 Figure 60. Global Serum Gonadotrophin for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 61. Serum Gonadotrophin for Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS